Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial

BACKGROUND: Vascular dementia (VaD) is the 2nd most common subtype of dementia after Alzheimer disease. Currently, there are no medications approved for treating patients with VaD. Tianmabianchunzhigan (TMBCZG) tablet is an active ingredient extracted from Gastrodia that has been reported to improve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Li, Ting, Ni, Jingnian, Zhang, Xuekai, Zhang, Meng, Li, Yang, Wang, Yongyan
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319825/
https://ncbi.nlm.nih.gov/pubmed/30572524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013760
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados